Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements

Abstract Background When use of a single antiseizure medication (ASM) fails to induce seizure remission, add-on therapy is justified. Perampanel (PER) is approved in Europe as adjunctive therapy for focal, focal to bilateral tonic-clonic seizures and generalized tonic-clonic seizures. Aim of the stu...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Paolo Bonanni, Antonio Gambardella, Paolo Tinuper, Benedetto Acone, Emilio Perucca, Giangennaro Coppola
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2021-10-01
Edice:	BMC Neurology
Témata:	Perampanel Epilepsy Delphi procedure Antiepileptic drugs Adjunctive therapy
On-line přístup:	https://doi.org/10.1186/s12883-021-02450-y
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!